Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study
Transplant International, EarlyView.
Source: Transplant International - Category: Transplant Surgery Source Type: research
More News: Hepatitis | Hepatitis B | Liver | Liver Transplant | Renal Failure | Study | Transplant Surgery | Transplants | Urology & Nephrology